EP300 and cervical carcinoma: The overall findings align with results from previous genomic studies on cervical cancer.30 The most frequently mutated gene was PIK3CA, observed in 45.2% of the patients, followed by EP300 (25.8%), RB1 (19.4%), FBXW7 (19.4%), and FAT1 (16.1%) (Figure 1A).